On October 27, 2021, Skan Group has announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and 2,768,506 existing shares and an over-allotment option of up to 500,000 shares, at CHF 54 per share, implying a total market
Tags :Advestra
Bachem Holding, an innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides, has raised CHF 583.5 million through an accelerated bookbuilding process by issuing 750,000 new shares at a placement price of CHF 778 per
Viseca, a provider of products and services in the area of cashless payment, from the issue of payment cards to the development of innovative finance management solutions, has secured a comprehensive refin
Katadyn Group, a Swiss-based specialist in portable water filters and trekking food, has been acquired by a group of entrepreneurs led by Kontivia, a long-term, down-to-earth investment company and
Following the Spin-off, Sulzer and Medmix shares will start trading separately on the SIX Swiss Exchange. In an offering of new shares, which took place at the same time, 7 million new shares were issued in
Advestra acted as legal counsel to Zurich Insurance Company (Zurich) in the establishment of its own service company Zurich Switzerland Services. Through the service company Zurich will
On September 7, 2021, Adecco Group successfully raised approximately EUR 232.29 m (CHF 252.96 m) through the placement of 5.1 m new shares by way of an accelerated bookbuild offering. The offering was done by way of a private
The insurer Zurich Switzerland, a Swiss subsidiary of the Zurich Insurance group, has acquired a 25% stake in the share capital of Brokerbusiness.ch., an insurtech start-up that operates a digital insurtech
XP, a Brazilian investment company listed on Nasdaq, has entered into an agreement with OHM Research regarding a strategic investment by XP. Advestra acts as leg
Idorsia biopharmaceutical company has placed CHF 600 million senior unsecured convertible bonds due 2028 in a private placement with institutional investors. The net proceeds of the